ESC 365 - Effects of phosphodiesterase-5A inhibition on right ventricular cardiomyocyte function in diabetic cardiomyopathy

HFA Premium Access

Effects of phosphodiesterase-5A inhibition on right ventricular cardiomyocyte function in diabetic cardiomyopathy

Session: Poster Session 2 - Basic Science - Metabolism

Topic: Cardiomyopathies

Speaker: Ms L. Martha (Debrecen, HU)

Event: Heart Failure 2019

Congress Presentation

About the speaker

Ms Lilla Martha

University of Debrecen, Debrecen (Hungary)

0 follower

17 more presentations in this session

Basic Science - Metabolism - Poster Discussant - 10:00-11:00.

Empagliflozin modulates GTP enzyme cyclohydrolase 1 in chronic heart failure

Speaker: Professor D. Pascual Figal (Murcia, ES)

The myocardial metabolism shift results to cardiomyocyte dedifferentiation in dilated cardiomyopathy and chronic heart failure.

Empagliflozin ameliorates post-infarction cardiac remodeling through overexpression of GTP enzyme cyclohydrolase 1

Speaker: Professor D. Pascual Figal (Murcia, ES)

Pharmacological mitochondrial stabilization to prevents adverse cardiac remodeling following MI using empagliflozin

Speaker: Professor D. Pascual Figal (Murcia, ES)

Access the full session

Poster Session 2 - Basic Science - Metabolism

Speakers: Ms L. Martha, Professor D. Pascual Figal, Professor D. Pascual Figal, Professor D. Pascual Figal

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by